These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37962682)

  • 1. Axillary cutaneous metastasis of colon cancer with microsatellite instability-high and BRAF V600E mutation treated with curative-intent surgery: a case report.
    Yamai D; Shimada Y; Ozeki H; Matsumoto A; Abe K; Tajima Y; Nakano M; Ichikawa H; Sakata J; Wakai T
    Surg Case Rep; 2023 Nov; 9(1):196. PubMed ID: 37962682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous metastasis of ascending colon cancer harboring a BRAF V600E mutation: A rare case report.
    Liao L; Cheng Q; Zhu G; Pei F; Ye S
    Medicine (Baltimore); 2020 May; 99(21):e20026. PubMed ID: 32481270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).
    Goldstein J; Tran B; Ensor J; Gibbs P; Wong HL; Wong SF; Vilar E; Tie J; Broaddus R; Kopetz S; Desai J; Overman MJ
    Ann Oncol; 2014 May; 25(5):1032-8. PubMed ID: 24585723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation.
    Tie J; Gibbs P; Lipton L; Christie M; Jorissen RN; Burgess AW; Croxford M; Jones I; Langland R; Kosmider S; McKay D; Bollag G; Nolop K; Sieber OM; Desai J
    Int J Cancer; 2011 May; 128(9):2075-84. PubMed ID: 20635392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
    de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
    Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite Instability with BRAF V600E Associated with Delayed Presentation but Poor Survival in Stage III Colorectal Cancer.
    Karki S; Sun W; Madan R; Lamsal K; Schmitt S; Godwin AK; Kasi A
    Fortune J Health Sci; 2023; 6(2):167-173. PubMed ID: 37736078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability.
    Nazemalhosseini-Mojarad E; Kishani Farahani R; Mehrizi M; Baghaei K; Yaghoob Taleghani M; Golmohammadi M; Peyravian N; Ashtari S; Pourhoseingholi MA; Asadzadeh Aghdaei H; Zali MR
    J Gastrointest Cancer; 2020 Mar; 51(1):53-62. PubMed ID: 30635874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
    Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
    Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer.
    Nakaji Y; Oki E; Nakanishi R; Ando K; Sugiyama M; Nakashima Y; Yamashita N; Saeki H; Oda Y; Maehara Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):151-160. PubMed ID: 27672042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.
    Zlobec I; Kovac M; Erzberger P; Molinari F; Bihl MP; Rufle A; Foerster A; Frattini M; Terracciano L; Heinimann K; Lugli A
    Int J Cancer; 2010 Dec; 127(11):2569-75. PubMed ID: 20162668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous Metastasis of Transverse Colon Cancer with an Aberrant Pattern of CK7/CK20/CDX2 and High Microsatellite Instability.
    Omiya M; Murata T; Sawaki A; Teshima S; Kawachi J
    Intern Med; 2023 Dec; 62(24):3625-3630. PubMed ID: 37164671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression.
    Landau MS; Kuan SF; Chiosea S; Pai RK
    Hum Pathol; 2014 Aug; 45(8):1704-12. PubMed ID: 24908142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report.
    Callebout E; Ribeiro SM; Laurent S; De Man M; Ferdinande L; Claes KBM; Van der Meulen J; Geboes KP
    BMC Cancer; 2019 Jun; 19(1):567. PubMed ID: 31185985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial.
    Taieb J; Zaanan A; Le Malicot K; Julié C; Blons H; Mineur L; Bennouna J; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Lepage C; Emile JF; Laurent-Puig P
    JAMA Oncol; 2016 May; 2(5):643-653. PubMed ID: 26768652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BRAF V600E-mutant colorectal cancers: Where are we?].
    Lièvre A; de la Fouchardière C; Samalin E; Benoist S; Phelip JM; André T; Lledo G
    Bull Cancer; 2020 Sep; 107(9):881-895. PubMed ID: 32674932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
    Chouhan H; Sammour T; Thomas ML; Moore JW
    J Surg Oncol; 2018 Dec; 118(8):1311-1317. PubMed ID: 30399198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF-V600E and microsatellite instability prediction through CA-19-9/CEA ratio in patients with colorectal cancer.
    Kasi PM; Kamatham S; Shahjehan F; Li Z; Johnson PW; Merchea A; Colibaseanu DT
    J Gastrointest Oncol; 2020 Apr; 11(2):236-241. PubMed ID: 32399264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary exploration of the effects of environmental factors on the microsatellite status of BRAF-mutated colorectal cancer.
    Tian B; Chen G; Shi X; Jiang L; Jiang T; Li Q; Yuan L; Qin J
    World J Surg Oncol; 2023 Aug; 21(1):264. PubMed ID: 37620872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous metastasis of cecum cancer with MSI-high and BRAFV600E mutation: a case report.
    Yunoki K; Yano T; Yoshimitsu M; Oshita K; Kubota T; Ishida M; Satoh D; Choda Y; Nakano K; Shirakawa Y; Matsukawa H; Idani H; Shiozaki S; Okajima M
    Surg Case Rep; 2021 Aug; 7(1):185. PubMed ID: 34406516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic complete response after laparoscopic surgery following treatment with nivolumab and ipilimumab for anticancer drug-resistant MSI-high descending colon cancer: a case report and literature review.
    Sawayama H; Miyamoto Y; Ogawa K; Ohuchi M; Hisano Y; Kato M; Tubakihara H; Yoshida N; Baba H
    Surg Case Rep; 2022 Dec; 8(1):223. PubMed ID: 36574162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.